Longli Kang
- Co-authors
- Tingting GengDongya YuanTianbo JinNa HeFeng TianQunying HuHua YangLi Wang
- Topics
- Pharmacogenetics and Drug Metabolism (16 papers)Drug Transport and Resistance Mechanisms (11 papers)Liver Disease Diagnosis and Treatment (5 papers)
- Cited by
- PharmacologyCancer ResearchOncology
- Journals
- GeneMedicineTetrahedron Letters
- Partner nations
- ChinaUnited States
In The Last Decade
Longli Kang
36 papers receiving 344 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 141
- Pharmacology 105
- Oncology 91
- Cancer Research 61
- Genetics 43
Countries citing papers authored by Longli Kang
This map shows the geographic impact of Longli Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longli Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longli Kang more than expected).
Fields of papers citing papers by Longli Kang
This network shows the impact of papers produced by Longli Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longli Kang. The network helps show where Longli Kang may publish in the future.
Co-authorship network of co-authors of Longli Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Longli Kang. A scholar is included among the top collaborators of Longli Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longli Kang. Longli Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 6 | |
| 4 | 23 | |
| 5 | 4 | |
| 6 | 8 | |
| 7 | 14 | |
| 8 | 20 | |
| 9 | 18 | |
| 10 | 1 | |
| 11 | 6 | |
| 12 | 6 | |
| 13 | 10 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 4 | |
| 17 | 18 | |
| 18 | 23 | |
| 19 | 25 | |
| 20 | 14 |
About Longli Kang
Longli Kang is a scholar working on Pharmacology, Nephrology and Oncology, having authored 36 papers that have together received 347 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (11 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Pharmacology (105 citations), Cancer Research (61 citations) and Oncology (91 citations). Longli Kang has collaborated with scholars based in China and United States. Frequent co-authors include Tingting Geng, Dongya Yuan, Tianbo Jin, Na He, Feng Tian, Tianbo Jin, Tianbo Jin, Qunying Hu, Feng Tian and Tianbo Jin. Their work appears in journals such as Gene, Medicine and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.